This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Jacqueline Clover
Jacqueline Clover
Associate
London +44 20 7067 2283 jclover@cov.com Download V-card

Jacqueline Clover is an associate in Covington’s life sciences transactional group, having joined the firm as a trainee solicitor in 2012.

Ms. Clover's practice covers a broad range of life sciences agreements, licensing and collaboration agreements, intellectual property law and commercial matters.

  • Advising AstraZeneca on its agreement to transfer to the company the rights to Almirall’s respiratory franchise for an initial consideration of $875 million on completion, and up to $1.22 billion in development, launch, and sales-related milestones.
  • Advising a leading biopharmaceutical business on its strategic partnership for the development of certain compounds used in the treatment of Parkinson’s disease.
  • Advising a leading biopharmaceutical business on its consortium partnership for a research project relating to neurodegenerative diseases.
  • Advising Innovacell on a collaboration and licensing agreement with Norgine for Europe (excluding Russia and Turkey), SADC and MENA regions in which Innovacell and Norgine will co-develop, and Norgine will commercialise, ICEF15 - an innovative personalised cell therapy to treat faecal incontinence.
  • Advising a spin-out pharmaceutical company developing treatments for inflammatory diseases of the gut and eye on a range of commercial agreements.

Pro Bono

  • Advising a children’s charity on a collaborative arrangement with a fostering agency for the provision of certain therapeutic and care services.
  • Advising an international charity on its acquisition of a microfinance bank.